RESEARCHER PROFILE
Assoc Professor Cedric Bardy, SAHMRI (2023)
Director of The Laboratory for Human Neurophysiology, Genetics & Stem Cells
South Australian Health and Medical Research Institute (SAHMRI) &
Professor, Flinders University
Adelaide, South Australia
Filmed November 2023
Associate Professor Cedric Bardy is the Director of The Laboratory for Human Neurophysiology, Genetics & Stem Cells, located at SAHMRI. South Australia.
His current research uses preclinical, patient-derived cell models to test innovative therapeutic strategies, with a current focus on Parkinson’s disease, brain cancer and childhood dementia (Sanfilippo syndrome).
His work has established a platform to facilitate the discovery and validation of treatments for brain disorders. Their research is at the frontier of human cellular neuroscience research and translational applications that benefit global public health.
In particular, Cedric is the inventor of BrainPhys; a neuronal medium broadly used to culture human neurons in vitro, commercialised by STEMCELL Technologies.
The ability to grow human brain cells in a petri dish opens up new possibilities for research and discovery in neuroscience.
The BrainPhys medium allows human brain cells to function as they would in the adult human brain, revolutionizing research in labs across the world.
Cedric Bardy’s research enables researchers to study human brain disorders in a more physiological context, potentially leading to new treatments for brain cancer, Parkinson’s disease, and Sanfilippo Syndrome.
Cedric Bardy’s international journey from France to Canada to Australia and then to the United States showcases the global nature of scientific research and collaboration.
The passion for neuroscience stems from the fact that everything we care about as humans is influenced by brain activity.
Cedric Bardy is passionate about finding ways to treat the brain when things go wrong, showing a deep commitment to neurological research.
-
Funding the best brains to beat brain cancer
The Charlie Teo Foundation is dedicated to funding and advancing research into brain cancer, with a particular focus on developing more effective treatments and finding a cure for this devastating disease.
Since its inception, the foundation has committed nearly $15 million to brain cancer research, funding notable projects in Australia and the United States. These projects explore innovative approaches to understand and treat brain cancer more effectively, with a focus on translating findings from animal studies to human applications. Charlie’s dedication to finding solutions for this devastating disease remains unwavering as he travels frequently to collaborate with global researchers. -
Professor Sandy Middleton
NURSING RESEARCH INSTITUTE, ST VINCENT’S HEALTH NETWORK SYDNEY, ST VINCENT’S HOSPITAL MELBOURNE AND AUSTRALIAN CATHOLIC UNIVERSITY
NEW SOUTH WALES, AUSTRALIA -
Discovery of RANK Ligand’s role in bone metabolism and the immune system to treat osteoporosis
Emeritus Professor Jack Martin’s research began a discovery cascade that led to the identification of a new protein and the development of a novel and effective drug therapy that is now used worldwide to treat osteoporosis, cancer and other diseases.
